Figure 2. Kaplan-Meier (KM) curves for progression-free survival (PFS) probabilities. (A) KM curves for PFS probabilities stratified by wild-type (WT) and PIK3CA–KD mutations, PIK3CA–HD mutations, PIK3CA–OD mutations, and other PI3K/AKT pathway aberrations (P/A). (B) KM curves for PFS probabilities stratified by wild-type (WT) and PIK3CA–KD mutations, PIK3CA–OD mutations, and other PI3K/AKT pathway aberrations (P/A). (C) KM curves for PFS probabilities stratified stratified by wild-type (WT) and PIK3CA–HD mutations. (D) KM curves for PFS probabilities stratified stratified by PIK3CA–HD mutations and PIK3CA–KD mutations. (E) KM curves for PFS probabilities stratified by PIK3CA–HD mutations and PIK3CA–OD mutations. (F) KM curves for PFS probabilities stratified by PIK3CA–HD mutations and other PI3K/AKT pathway aberrations (P/A).